Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|April 6, 2017
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with TrastuzumabAndrew McGuire, Olga Kalinina, Emma Holian, et al.
American Journal of Respiratory and Critical Care Medicine|October 24, 2019
Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell ProfilesDavid T Siefker, Luan Vu, Dahui You, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2015
Novel 11β-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffoldRosana Leiva, Constantí Seira, Andrew McBride, et al.
Bioorganic & Medicinal Chemistry|November 25, 2015
Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitorsElena Valverde, Constantí Seira, Andrew McBride, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
A series of 2(Z)-2-benzylidene-6,7-dihydroxybenzofuran-3[2H]-ones as inhibitors of chorismate synthaseMichael G Thomas, Chris Lawson, Nigel M Allanson, et al.
Plos One|July 23, 2013
miR-379 regulates cyclin B1 expression and is decreased in breast cancerSonja Khan, Cathy L Brougham, James Ryan, et al.
Cardiology|November 24, 2015
Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic HypertensionYasmin S Hamirani, Bijoy K Kundu, Min Zhong, et al.
International Journal of Colorectal Disease|August 21, 2012
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapyElrasheid A H Kheirelseid, Nicola Miller, Kah Hoong Chang, et al.
Addiction (Abingdon, England)|February 15, 2007
Exploring the relationship between genetic and environmental influences on initiation and progression of substance useTom Fowler, Kate Lifford, Katherine Shelton, et al.
Pageof 7